Univercells Technologies partnered with Repligen to integrate MAVEN® Real Time Glucose Control within scale-X bioreactors, enabling continuous, nondestructive monitoring of glucose and lactate levels during viral vector and vaccine manufacturing. This process analytical technology enhances control over cell cultures, optimizing media and feeding strategies to improve bioprocess efficiency and scalability of advanced therapeutic production.